Table 1.
New opportunities | Challenges |
---|---|
Improved image quality and high signal to noise | |
• Decrease population sampling size which will lead to faster translation of new/existing radiotracers • No need for post-filtering • Reconstruct images at smaller voxel size • Measure/correct motion using PET data • Increase specificity/sensitivity • Increase reproducibility • Detect low-grade uptake • Detect disease at earlier stages |
• Amend standardisation values/harmonisation • Substantially non-uniform sensitivity along the axial field of view |
Short imaging protocols | |
• High patient throughput • Avoid anaesthesia in children • Scan ICU patients • Reduce motion artefacts • Reduce patient inconvenience and consequently increase compliance • Increase screening high-risk but otherwise healthy individuals |
• More hot uptake rooms needed |
Imaging with lower doses (as many more otherwise lost counts can be measured) | |
• Imaging radiosensitive populations (paediatrics, pregnant women) • Imaging larger populations which will lead to faster translation of new/existing radiotracers and better understanding of health/disease • Less affected by radiophobia, which will help replace other diagnostic procedures • Use radiotracers with poor labelling efficiency or low positron emission branching ratio • Wider acceptance for use in clinical trials • Imaging the same patient more sessions, which will lead to frequent/accurate therapy evaluation |
• Still requires CT for attenuation correction, which poses a significant limit to dose reduction (unless CT scan is avoided.) • Intrinsic 176Lutetium radiation adds background noise |
Imaging kinetics with greater temporal range | |
• Imaging slower biological processes (e.g. radionuclide therapy and immunotherapy) • Imaging faster biological process due to higher temporal sampling • Imaging biological processes for much longer half-lives of the radiotracer • Derive accurate input function from short frames • Extract more relevant/valuable information from one scan • Increase specificity/sensitivity • Increase reproducibility • Identify input function delay in different organs • Enabling imaging more than one tracer simultaneously |
• Require accurate motion correction • Require input function • Require metabolites • Require appropriate kinetic model due to kinetic heterogeneity • Slow computational times for reconstruction, data corrections and kinetic modelling |
Imaging longer axial FOV | |
• Imaging multiple regions at the body and investigate potential correlations • Biodistribution of newly developed (potentially radiolabelled) drugs • Improve accuracy of dose estimation for radionuclide or other radiomolecular therapies • Measure input function from aortas |
• Requires checks of structural limits of the floor • Expensive (when compared to conventional PET) • May require bigger space • Makes difficult to withdraw blood samples or other interventions during the scan • Claustrophobic patients will be harder to scan • Increases environmental footprint • Adaptation of current QA procedures with longer phantoms which can be more difficult and time-consuming to handle • Data storage and networking infrastructure • If it replaces several conventional scanners or breaks, no other scanners available |